Metastatic Pancreatic Adenocarcinoma clinical trials

Explore recruiting metastatic pancreatic adenocarcinoma clinical trials.

Recruiting metastatic pancreatic adenocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Pancreatic Adenocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma with KRAS p.G12C mutation

France, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 2, Open-Label, Randomized Study to Assess the Efficacy and Safety of Zolbetuximab (IMAB362) in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma

Ireland, Spain, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase Ib-II, non-randomized, open-label study of Tumor Treating Fields (TTFields, 150kHz) concomitant with modFOLFIRINOX for front-line treatment of metastatic pancreatic adenocarcinoma

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to compare Onivyde manufactured at two different production sites in adult participants with advanced cancer in the pancreas

Spain, Hungary, Italy, France

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

An open-label, randomised, multicentre, phase III study of irinotecan liposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine in subjects who have not previously received chemotherapy for metastatic adenocarcinoma of the pancreas

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metastatic Pancreatic Adenocarcinoma trials by city

Metastatic Pancreatic Adenocarcinoma clinical trials

Recruiting metastatic pancreatic adenocarcinoma studies right now

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

A Study of MGC026 in Participants With Advanced Solid Tumors

Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma